Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates. Efficient synthesis reduces costs and ensures supply chain reliability for antitumor drug development.
Patent CN113004236A details a green POMs-catalyzed route for phthalide derivatives, offering cost-effective and scalable production for pharmaceutical intermediates.
Patent CN112920173A details a chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing for oncology drug development.
Novel cobalt-catalyzed asymmetric Friedel-Crafts reaction for high-purity oxindoles. Cost-effective alternative to noble metals with scalable production capabilities.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Novel base-promoted route for 5-CF3-1,2,3-triazoles avoids toxic azides. Offers scalable, metal-free synthesis for high-purity pharmaceutical intermediates.
Novel metal-free oxidative cyclization method for high-purity triazole intermediates. Reduces cost and simplifies supply chain for pharma manufacturing.
Patent CN112939891A reveals a metal-free visible light protocol for biphenyl benzothiazole. This method offers significant cost reduction and simplified supply chains for pharmaceutical intermediates.
Novel two-step route for o-alkynyl phenylcyclobutanone and naphthalenone synthesis offering high yield and scalability for pharma applications.
Novel binaphthyl phosphoric acid catalyzed route offers mild conditions and high purity for scalable pharmaceutical intermediate manufacturing supply chains and cost reduction.
Patent CN107216326B enables mild synthesis of phenanthridine derivatives, ensuring high purity and supply chain stability for pharmaceutical intermediates globally.
Patent CN109384789B details a mild Ag(I)-catalyzed route to indoloazepines, offering cost-effective manufacturing for pharmaceutical intermediates.
Novel chiral phosphoric acid catalyzed resolution method for high-purity axially chiral oxindole-substituted styrenes, offering scalable synthesis for pharmaceutical intermediates.
Patent CN117088826B enables visible light oxazole synthesis. Offers green chemistry benefits and supply chain stability for pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalysis enables high-yield, high-ee synthesis of anticancer intermediates, ensuring cost-effective and reliable supply chain solutions.
Patent CN105085208B reveals mild Pd-catalyzed benzofluorenone synthesis. Offers cost reduction and supply reliability for fine chemical intermediates.
Patent CN108558692B reveals a mild NHC-catalyzed route for amide synthesis, offering significant cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Novel quinoline imidazole ligand enables high-yield asymmetric hydrogenation. Reduces costs and improves supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN110156800A reveals mild NHC-catalyzed synthesis for high-purity pharmaceutical intermediates. Enables cost reduction and scalable supply chain solutions.
Patent CN101492407B details a mild organocatalytic route for high-purity beta-indolaldehyde, offering significant cost and environmental benefits for pharma manufacturing.